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Astrocytes are the most abundant cells of the central nervous system; they have a
predominant role in maintaining brain metabolism. In this sense, abnormal metabolic
states have been found in different neuropathological diseases. Determination of
metabolic states of astrocytes is difficult to model using current experimental approaches
given the high number of reactions and metabolites present. Thus, genome-scale
metabolic networks derived from transcriptomic data can be used as a framework
to elucidate how astrocytes modulate human brain metabolic states during normal
conditions and in neurodegenerative diseases. We performed a Genome-Scale
Reconstruction of the Human Astrocyte Metabolic Network with the purpose of
elucidating a significant portion of the metabolic map of the astrocyte. This is the first
global high-quality, manually curated metabolic reconstruction network of a human
astrocyte. It includes 5,007 metabolites and 5,659 reactions distributed among 8
cell compartments, (extracellular, cytoplasm, mitochondria, endoplasmic reticle, Golgi
apparatus, lysosome, peroxisome and nucleus). Using the reconstructed network, the
metabolic capabilities of human astrocytes were calculated and compared both in normal
and ischemic conditions. We identified reactions activated in these two states, which
can be useful for understanding the astrocytic pathways that are affected during brain
disease. Additionally, we also showed that the obtained flux distributions in the model,
are in accordance with literature-based findings. Up to date, this is the most complete
representation of the human astrocyte in terms of inclusion of genes, proteins, reactions
and metabolic pathways, being a useful guide for in-silico analysis of several metabolic
behaviors of the astrocyte during normal and pathologic states.
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INTRODUCTION
Astrocytes are the most numerous glial cells found in the vertebrate brain (Verkhratsky et al.,
2014). Essentially, these cells have a major role in the functions of the central nervous system and
participate in key processes such as neurogenesis (Figueiredo et al., 2014), synaptogenesis (Hughes
et al., 2010), neuro-inflammation (van Dijk et al., 2015) and neuro-modulation. Considering the
strong metabolic cooperation that exists between neurons and astrocytes (Barreto et al., 2011a),
increasing evidence has shown the importance of astrocytic dysfunction in the pathophysiology
of neurological disorders, such as epilepsy, stroke, inflammatory diseases, Alzheimer’s disease,
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Parkinson’s disease, and amyotrophic lateral sclerosis (Cabezas
et al., 2012; Guillamón-Vivancos et al., 2015). The role played by
astrocytes in brain functions has not been extensively assessed,
despite evidence suggesting that astrocyte dysfunctionmight play
a unique role in promoting multiple brain disorders (Barreto
et al., 2011b; Cabezas et al., 2012; Acaz-Fonseca et al., 2014).
Thus, the manner in which astrocytes respond to physiological or
pathological conditions are likely important in determining the
outcome of a brain damage. Hence, the metabolic interactions in
astrocytes require more investigation for a better understanding
of the metabolic activity of these cells in response to different
conditions that involved the brain. The identification of
metabolic pathways of astrocytes is a difficult task that can be
simplified by mathematical models. Mathematical models allow
the systematic analysis of complex biological phenomena. System
approaches integrates mathematical model formulations with
computational modellings, that could represent the biochemical
knowledge used to strengthen experimental results (Palsson,
2009; Hyduke et al., 2013). The expression of biological
phenomena using mathematical models has been used to
understand how information, energy and matter behaves in the
cell and to get an efficient statistical inference in experimental
research by studying the dynamical behavior of cell (Najafi et al.,
2014; Vanlier et al., 2014; Özcan and Çakır, 2016; Rajkumar et al.,
2016).
A metabolic reconstruction is built from a variety of biological
knowledge source such as integration of high-throughput omic
data, biological data bases, literature (Najafi et al., 2014). The
goal is to obtain a robust model, which can be used to infer
new properties; for example, the genome-scale metabolic human
known as Recon and published in 2015 has been one of the most
annotated model for humanmetabolism (Thiele et al., 2013), and
it has been used in different areas including synthetic biology (He
et al., 2016), metabolomics and cancer research (Petoukhov et al.,
2014).
Moreover, the genome-scale network reconstructions have
been used in deciphering the scope and functional implications of
the regulated and dysregulated metabolism in different systems,
making themselves an useful and promising tool to determine
the role of cells in metabolic responses during different stimuli
and insults (Weckwerth and Morgenthal, 2005). Some examples
of the use of gene microarrays to model genome-scale metabolic
reconstructions have been recently reported (Palsson, 2009;
Hyduke et al., 2013; Aung et al., 2014). In this regard, it is possible
to analyze and predict metabolic behaviors at different cell levels
in order to determine how an individual component interacts
in the systems and influences on the total cell function (Schlage
et al., 2011; Agren et al., 2012; Sertbas¸ et al., 2014).
Specific metabolic models applied to different human brain
systems have been developed previously, including astrocyte-
neuron coupled models in an environment that simulates
metabolic variations experienced in different neurodegenerative
diseases (Cakir et al., 2007; Lewis et al., 2010; Calvetti and
Somersalo, 2012, 2013).In this aspect, astrocyte models have
been developed to determine calcium waves during astrocyte
interaction with other cells (Gibson et al., 2008). Additionally,
Cakir et al. reconstructed a brain metabolic network based
on a previous model by adding transcriptional data of six
neurodegenerative diseases. This model included 630 metabolic
reactions, of which 253 of the reactions took place in neurons
while 299 of them were astrocytic. The model predicted
transcriptional factors such as USF1, SP1, and FOX that have
regulatory roles in the neurodegenerative diseases. To date, most
of reconstructed metabolic networks strive to include reactions
involved in astrocytes by literature revision. Therefore, many
genes and metabolic reactions are not included in these models.
Since these models contain small and specific metabolic systems,
the main goal of our study was to generate the most complete
genome-scale metabolic reconstruction (GSMM) of a human
astrocyte based on genomic, transcriptomic, biochemical and
physiological data.
The work flow described in our study integrates brain-specific
omics data and literature-based manual curation to generate
high quality GSMM of human astrocyte. The model includes
5,659 reactions and 5,007 metabolites which are distributed in
eight cell compartments (Extracellular, cytoplasm, mitochondria,
endoplasmic reticle, Golgi apparatus, lysosome, peroxisome
and nucleus). The reconstruction covers a large number of
metabolic reactions that belong in most part to the energetic
metabolism including carbohydrate metabolism, amino acid
metabolism, xenobiotics biodegradation, nucleotide metabolism
and metabolism of cofactors and vitamins. Furthermore, the
model was validated using a flux Balance Analysis (FBA), for
prediction of fluxes in the simulation. Additionally, network
evaluation was performed to examine if the model was capable
to generate the common astrocytic metabolites reported by the
literature (Zwingmann et al., 2000; Shanker et al., 2001; Lebon
et al., 2002).
On the other hand, mathematical modeling approximations
under restrictions can help to understand the metabolic changes
that occur in different pathologies (Lewis et al., 2010; Zhao
and Huang, 2011; Bordbar and Palsson, 2012). Such models
have been a helpful tool for studying roles of different cells in
pathological states. In these aspect, we simulated and determined
the predictive accuracy of our model during ischemic disease,
through a process called random sampling, which allowed
to determine the range of possible steady-state fluxes in the
network. Ischemic related pathologies are one of the leading
causes of long term impairment and death (Arauz and Ruíz-
Franco, 2012). During ischemic brain damage, the astrocytes have
diverse and important functions that involve metabolic responses
important for preventing the extent of brain damage. The fluxes
in ischemic astrocyte network were coherent with experimental
results reported in literature. Therefore, this metabolic model
serve as an effective predictive model that represents a
large- scale hypothesis of how astrocyte work in different
states.
To our knowledge, this is the first model of astrocytic
metabolism at genomic scale that could be used for future studies
on the integration of multiple biological data, identification
of new therapeutic targets, recognition of biomarkers and
development of new and improved neuroprotective strategies for
common diseases that involve nervous system. Additionally, this
reconstruction is fully compatible with Human metabolic atlas,
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which will facilitate studies of astrocyte-cells interactions in the
context of neurodegenerative diseases.
MATERIALS AND METHODS
Construction, validation and analysis of the Genomic-Scale
Metabolic Model of Astrocyte was developed in four stages
following the methodology proposed by Thiele and Palsson
(2010) Manuscript (2011) (Figure 1).
Stage 1: Preliminary Reconstruction of the
Genome Scale Metabolic Network Model
On this first stage, astrocyte genomic, transcriptomic,
biochemical and physiological data information was collected
according to Baart y Martens (Baart and Martens, 2012)
specifications. To model the astrocyte metabolic phenotype,
statistical analysis of transcriptomic data obtained from human
fetal cortical astrocytes (GEO ID: GSE53404) (Malik et al., 2014)
was performed. Additionally, to establish a list of genes with their
respective enzymatic products, an analysis of gene expression
arrays was performed using Bioconductor (Huber et al., 2015).
Finally, the HMA (humanmetabolic atlas) (Pornputtapong et al.,
2015) was used to obtain the chemical reactions associated to
identified enzymes.
Stage 2: Manual Refining and Metabolic
Model Reconstruction
Curation and refining of the network content was carried out
in order to guarantee the presence of all enzymes of a mature
human astrocyte and to ensure that the global network was
balanced in mass-energy terms. In this aspect, inconsistencies in
stoichiometry, reversibility and cellular location of every reaction
were corrected by checking different data bases and literature
(Binder et al., 2014; Kanehisa et al., 2014; Uhlen et al., 2015).
Therefore, the corresponding metabolic pathways were assigned
to the 3,864 reactions identified in stage one, these reactions were
manually assembled to ensure network connectivity. Transport
and exchange reactions were added to connect all compartments.
FIGURE 1 | Iterative procedure for reconstruction of the genome scale metabolic network of human astrocyte. Construction, validation and analysis of the
Genomic-Scale Metabolic Model of Astrocyte, was developed in four stages following the methodology proposed by Thiele and Palsson (2010). The omics data set
was integrated with human metabolic network (HMA). Following the initial reconstruction process, the reconstruction is converted into a mathematical model format
that can be used for computation. Afterwards, flux balance analysis (FBA) and random sampling was used to adjust and evaluate restrictions imposed on the model
under different conditions. Finally, the analysis predictions were compared and validated against experimental studies.
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In this sense, a schematic script (Supplementary Data 1) with this
purpose was performed, so it would be possible to extract the
necessary transport and exchange reactions from the HMA.
In order to assess the predictability of the generated model, a
second script (Supplementary Data 2) that allowed gap detection
in the entire metabolic network, identifying dead endmetabolites
present all over the model, was written. A dead-end is a
metabolite that cannot be either produced or consumed by
the reactions that are part of the network. These generated
fragments of the network that are isolated due to the lack of
reactions that connect them. Every “dead end” was manually
examined to identify the possible reaction that would resolve
the connection breach. To determine the metabolic context in
which the dead end was developed, an intensive literature search
using different databases such as KEGG (Kyoto Encyclopedia of
Genes and Genomes) (Kanehisa et al., 2014), IntEnz (Integrated
relational Enzyme database) (Fleischmann et al., 2004) and HMA
(Pornputtapong et al., 2015) was carried out. Finally, gaps were
solved by adding reactions that either produce or consume the
dead-end metabolite. Reactions added to the model were verified
in HPD (Human Protein Database) (Uhlen et al., 2015) to ensure
presence of the enzyme in the astrocyte.
Stage 3: Reconstruction Conversion to a
Predictive Mathematic Model Based on
Restrictions
The metabolic reconstruction obtained in previous stages was
converted into a mathematic model (stoichiometric matrix)
using MATLAB 2012b1 (Lanz et al., 2013). To define the
flux space in steady-state, restrictions were imposed based
on physical-chemical principles like stoichiometric coefficient,
directionality, and input/output restrictions of the different
metabolites that compose the network.
All network reactions of the model were mathematically
described and assembled in a stoichiometricmatrix (S), where the
mass balance equation system for all metabolites is represented as
follows:
s ∗ v = 0
s = m ∗ n
Where S is a stoichiometric matrix ofm size times n.m represents
the number of metabolites (3,892) and n the number of reactions
including exchange reactions (5,659); v is the reaction flux vector
to be identified. Restrictions for every reaction have the form:
Vi(Lower limit) ≤ V ≤ Va(Upper limit)
Where Vi and Va are represented by inferior and superior limits,
respectively, which define maximum and minimum allowable
flux limits for every reaction, limited between -1,000 and 1,000
(Rajkumar et al., 2016). To reduce even more the solution space,
and to improve the representation of the biological phenomena
under study, additional restrictions were established in the
model based on astrocyte metabolic flux rates in excitatory
1The MathWorks, Inc. MATLAB and Statistics Toolbox Release 2012b.
neurotransmission (Lanz et al., 2013). Glutamate release from
neuron to extracellular space and its re-uptake by astrocytes
for its subsequent processing was established as the normal
physiological condition for the purposes of this paper. Oxygen
and glucose are the main substrates that fuel brain activity. Since
these substrates normally enter extracellular space depending on
the cellular metabolic state, availability of the twometabolites was
considered to define the astrocyte excitatory physical condition
(Shen et al., 1999).
Previous reports claim that brain glucose intake rate in a state
of glutamatergic excitatory activity is 0.980 µmol/g of tissue/min
(Shen et al., 1999). Specifically, glucose uptake rate by astrocytes
corresponds to half the glucose that enters the brain (0.490
µmol/g of tissue/min) (Mason et al., 1995; Gruetter et al., 2001).
As for oxygen, it was reported that 30% of the total is consumed
by astrocytes (0.530 µmol/g of tissue/min) in the brain cortex
(Zwingmann et al., 2000). Additionally, it was integrated the
metabolic flux rates of the exchange reactions that are available
in the literature such as lactate, carbon dioxide, ammonia, amino
acids, etc. The imposed restrictions on the network are shown in
Table 1.
Ischemia induces energy withdrawal in astrocytes, since this
injury reduces the flux of oxidative substrates such as glucose and
TABLE 1 | Uptake and release rates of different metabolites in astrocyte
network.
Constraints for the normal physiological condition
Metabolite Metabolic rate µmole/g/min References
Glucose 0.16 Shen et al., 1999; Gruetter
et al., 2001
Linoleate 0.0011 Aureli et al., 1997
Linolenate 0.0009 Aureli et al., 1997
Histidine 0.0025 Amaral et al., 2011
Isoleucine 0.0004 Murín et al., 2009
Leucine 0.0145 Hannuniemi and Oja, 1981
Lysine 0.011 Hannuniemi and Oja, 1981
Methionine 0.0017 Lanz et al., 2013
Threonine 0.0008 Shen et al., 1999
Valine 0.0018 Westergaard et al., 1993
O2 0.515-0.530 Zwingmann and Leibfritz, 2003
Co2** 0.530 Zwingmann and Leibfritz, 2003
Asparagine 0.0037 Lebon et al., 2002
Tyrosine 0.0017 Lebon et al., 2002
Arginine 0.0020 Cruz and Cerdán, 1999
Glycine 0.0086 Zwingmann et al., 2000
Proline 0.0066 Zwingmann and Leibfritz, 2003
Serine 0.0016 Verleysdonk et al., 1999
Glutamate 0.232 Zwingmann et al., 2000
Ornithine 0.0031 Verleysdonk et al., 1999
Acetoacetate 0.0015 Chateil et al., 2001
Pyruvate 0.007 Verleysdonk et al., 1999
Cystine 0.0045 Shanker et al., 2001
All the constrains shown are in units of umol/min/g of proteins Asterisk (*) indicate release
rate. These constraints were applied for all conditions in this study.
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oxygen (Thorén, 2006; Liu et al., 2015). This, in turn, slows down
or stops the synthesis of ATP through glycolysis and oxidative
phosphorylation (Yu et al., 2002; Rossi et al., 2007; Takano et al.,
2009). To simulate ischemic conditions in the model, a reduction
in the oxygen flux was performed, as well as in glucose supply.
Hypoxic condition was simulated by progressive reductions of
20% over the maximum rate of oxygen consumption defined in
normal physiological conditions (in a range of 0–0.530 µmol/g
of tissue/min). Glucose deprivation was generated by progressive
reductions of 20% over the maximum glucose intake defined in
normal physiological conditions (in a range of 0–0.490µmol/g of
tissue/min). Additionally, experimental data of the flux was taken
from various metabolic pathways in astrocyte cultures exposed
to oxygen and glucose deprivation (Cruz and Cerdán, 1999;
Amaral et al., 2011). Such procedure allowed a characterization
of a feasible flux distribution for the ischemic metabolic state in
astrocytes.
Stage 4: Network Evaluation
Flux balance analysis (FBA) was used to adjust and evaluate
restrictions imposed on the model under normal physiological
conditions (Orth et al., 2010). In this aspect, the most probable
metabolic reactions used by astrocyte under physiological
conditions were established. Moreover, this analysis allowed
to define the distributions of optimal flux and evaluate the
metabolic capabilities of the astrocyte model, which ensured
that the model presented in this research correctly simulated
the physiological activity of an astrocyte. Therefore, the
identification of metabolic capabilities of the network was not
only useful to relate it with expected phenotype, but also to find
the dead-end reactions when under any metabolic reaction a
specific metabolite is not produced nor used by a reaction or set
of reactions in the network.
To establish the metabolic functions performed by the
reconstructed system, reactions known as objective functions
(OF) were defined. These reactions allowed to establish the
astrocytic metabolism under an physiological excitatory
stimulus. Two objective functions were considered because
according to literature, astrocyte metabolism its highly
dependent on (1) ATP derived from energetic pathways and (2)
the glutamate and glutamine exchange between astrocytes and
extracellular space (Parpura et al., 2016). This objective functions
are described in Table 2.
TABLE 2 | Metabolic objective functions used in the analysis of the
astrocytic network.
Metabolic function Equation
(A) ATP production ADP[m] + 4 H+[c] + Pi[m] =>
ATP[m] + 3 H+[m] + H2O[m]
(B) Maximization of glutamate
and glutamine
Glutamate[x] + Glutamine[c] =>
Glutamate[c] + Glutamine[x]
(A) Cells tend to maximize ATP synthesis or optimize the metabolic uptake of the
surroundings to supply cellular demands. (B) Glutamate input and glutamine output were
chosen considering the main role that the astrocyte has in glutamate detoxification of the
extracellular means for its later conversion to glutamine.
Additionally, random sampling of flux space was used
to define and limit the solution space of the model in
ischemic state (Wiback et al., 2004). Restrictions imposed to the
solution space were given by stoichiometry, reversibility and the
experimental flux measuring mentioned above. The “Random
Sampling” (Wiback et al., 2004) is an algorithm implemented
in RAVEN (Reconstruction, Analysis and Visualization of
Metabolic Networks) (Agren et al., 2013). This algorithm
encloses the region of solutions allowed in a parallelepiped
with the same dimensions of the solution space (stoichiometric
matrix). In this way, it generates random points on the corners of
the parallelepiped that are located in a zone of possible solution.
Values of the flux measures were different in the simulations of
these two conditions. To calculate the difference between the
fluxes and to quantify the importance of the change of every flux,
an approximation based on Z score was used. To obtain Z score,
standard and media deviations of every flux in each condition
were obtained. Z-score is equal to the difference of the media of
every one of the conditions divided into the standard deviation
of this difference:
ZiFlux =
E2 (Vi)− E1(Vi)
√
Var2 (Vi)+ Var1(Vi)
(1)
The difference between the averages in the numerator follows
a normal distribution (according to the theorem of the central
limit) with a standard deviation equal to the standard deviation of
the flux (denominator) divided by the square root of the number
of samples. Therefore, Z itself follows a normal distribution
with a standard deviation equal to the inverted square root of
the number of samples. To keep the error lower than 0.15,
five thousand simulations were performed, which reduced error
probability to 0.999%. Results obtained at different biological
states were validated by comparing metabolic changes with
literature reports making an extended bibliographic search in
databases such as OMIN (Online Mendelian Inheritance in
Man) (Hamosh et al., 2005), HMDB (The Human Metabolome
Database) (Wishart et al., 2013) and literature in NCBI (The
National Center for Biotechnology Information)2.
RESULTS
Characteristics of Genome-Scale
Reconstruction of the Human Astrocyte
We have reconstructed a novel astrocyte metabolic model based
on genomic, transcriptomic, biochemical and physiological data.
The astrocyte metabolic network is composed by 3,765 genes,
862 enzymes, 5,007 metabolites and 5,659 reactions from which
237 are exchange reactions and 1,948 are transport reactions
(Table 3). The model is available both in excel format and
in SBML format as supplement (Supplementary Data 3) and
uploaded in BioModels (MODEL1608180000) (Juty et al., 2015).
The present model for astrocyte metabolism can be classified
based on the following categories: (A) enzymatic classification
(EC-number); (B) gene association; (C) subcellular locations and
(D) metabolic pathways. Concerning to protein classification
2http://www.ncbi.nlm.nih.gov/.
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TABLE 3 | Summary of the composition of the astrocyte metabolic
network characteristic.
No. genes No. reactions No. metabolites
Extracellular space 315 1,190 461
Peroxisome 187 381 353
Mitochondria 668 923 677
Cytosol 2,756 1,604 2,251
Lysosome 102 429 378
E. reticulum 369 591 530
A. Golgi 191 182 275
Nucleus 104 118 67
Boundary 0 0 18
(EC-number), it was observed that 35% of total reactions of the
model, are catalyzed by transferase enzymes such as glutathione
S-transferase, glutathione peroxidase, and catalase. This group
of enzymes have an essential role for astrocyte metabolic
function, detoxification functions and neuroprotective capacity
of astrocytes (Hertz et al., 2007). The next group of enzymes
with high intervention in the model was oxidoreductases (28%),
followed by hydrolases (20%), ligases (8%), lyases (6%) and
isomerases (3%) (Figure 2A).
Reactions were also classified on a gene-association basis. In
this aspect, 58% of model reactions, have a direct association
with different genes, and our results show that many are related
to a wide array of brain diseases. 42% of reactions are not
associated to any gene and were classified as non-associated
to gene interchange reactions (30%), non-associated to gene
transport reactions (9%) and non-associated to gene intracellular
reactions (3%); (Figure 2B).
Regarding subcellular location, cytosolic and mitochondrial
reaction contributed with 59% of the total reactions in the
model. 23% of reactions belonged to peroxisome, lysosome,
endoplasmic reticulum, golgi apparatus and nucleus. Transport
reactions among the different organelles and extracellular space
represented 18% of total reactions (Figure 2C).
Reactions were gathered around different metabolic routes
(Figure 2D), being 39% of reactions included in the model part
of glycolysis, pentose phosphate pathway (PPP), tricarboxylic
acid cycle (TCA) and oxidative phosphorylation, which are the
main energetic pathways used by astrocyte (Bouzier-Sore and
Pellerin, 2013). Specific astrocyte anaplerotic reactions (Bélanger
et al., 2011), such as malic enzyme and carboxylase pyruvate,
were included in these pathways. 34% of the reactions were
involved in metabolic pathways of biosynthesis and catabolism
of different amino acids (glycine, glutamate, serine, threonine,
cysteine, methionine, alanine, aspartate, and arginine). Finally,
22% of the reactions belonged to fatty acid metabolism inclusive
both biosynthesis and beta oxidation. Other metabolic pathways
accounted to 8% of the total reactions, including detoxification of
reactive oxygen species (ROS).
Model Capabilities Evaluation
Due to the high coverage of gene-associated reactions, is possible
to use this model for the integrated computational analysis of
astrocyte metabolism and genomic data (Sertbas¸ et al., 2014).
The metabolic capabilities of the reconstructed network were
calculated through two objective functions. This functions, tested
network response and captured metabolic scenarios developed
in astrocytes in different conditions such as maximization of
ATP production, glutamate absorption and glutamine release
(Shen et al., 1999). Both objective functions have important
physiological implications. The first one ensures the use of
diverse metabolites to supply cellular demand of energy (Hertz
et al., 2007). The second one ensures glutamate input and
glutamine output considering that astrocyte has a main role
in glutamate detoxification of the extracellular space for its
later conversion to glutamine (Table 2). The results presented
here were generated from flux distributions adjusted to the
metabolic behavior of human astrocytes in response tomaximum
requirements of ATP, glutamate capture and later conversion
to glutamine. The model was reconstructed in such a way
that pathways of major importance to astrocyte metabolism are
included (Figure 3).
Energetic Metabolism
Astrocytes play a major role in the development of energetic
metabolism, given that these cells are well equipped to carry
out the metabolic regulation of glucose in response to neuronal
activity (Perea et al., 2014). Blood glucose captured by astrocytes
can be stored as glycogen, metabolized into lactate, or finally
coupled to the TCA cycle or pentose phosphate pathway (Kreft
et al., 2012). When performing simulation and distributing
flux space to generate a maximum ATP capacity, we observed
a higher flux in oxygen and glucose uptake. Thus, glucose
was mainly metabolized through glycolysis coupled to the
TCA cycle and oxidative phosphorylation and consequently,
activating the metabolic fluxes associated with these
pathways.
We observed that the amount of glucose metabolized in
the pentose phosphate pathway was highly decreased when
compared to glycolysis. In this regard, the flux rate through
the reaction mediated by hexokinase enzyme (EC 2.7.1.1), main
modulator of phosphorylation reaction of glucose to glucose-
6-phosphate, was calculated in 0.49 µmol/g/min. This value is
similar to previous experimental results obtained by nuclear
magnetic resonance spectroscopic approach, which reported
0.41 ± 0.03 miccromol. g(−1). min(−1) (Gruetter et al., 2001;
Amaral et al., 2011). The activation of this reaction ensured
fluxes through glycolysis and allowed to use the product
of this reaction (glucose-6-phosphate) as substrate in several
processes. Moreover, we observed flux Activation by Pyruvate
kinase (EC:2.7.1.40) and lactate dehydrogenase (1.1.1.27) in
physiological conditions. Pyruvate kinase catalyzes the transfer
of a phosphate group from phosphoenolpyruvate (PEP) to
adenosine diphosphate (ADP), yielding onemolecule of pyruvate
and one molecule of ATP (Ivanov et al., 2014). Consequently,
ATP production is activated, as well as nicotinamide adenine
dinucleotide (NADH), which is essential to keep a continuous
glycolytic flux. The flux through lactate dehydrogenase (1.1.1.27),
an enzyme that catalyzes pyruvate and NADH conversion to
lactate and NAD+, was estimated in 0.99 µmol/g/min (Amaral
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FIGURE 2 | Characteristics of the reconstructed genome scale metabolic network. The model reconstruction has been classified on the basis of (A)
enzymatic classification enzymatic classification (EC-number); (B) gene association; (C) subcellular locations and (D) Main metabolic pathways.
et al., 2011). Likewise, flux value in the output reaction of lactate
to extracellular space was 0.98 µmol/g/min (Zwingmann et al.,
2000; Amaral et al., 2011). The comparison of flux proportions
of glucose input and pyruvate final production in the model
corresponds to what is reported experimentally by spectroscopy
of C13 nuclear magnetic resonance methodologies (Schousboe
et al., 1997). Importantly, under aerobic conditions, pyruvate
is formed and can be metabolized via tricarboxylic acids cycle
(Zwingmann et al., 2000; Kreft et al., 2012).
Regarding the activity of the tricarboxylic acid cycle (TCA),
it was observed an initial metabolic flux activation by citrate
synthase (EC:2.3.3.1). This enzyme catalyzes the first reaction
of the acetate condensation coming from acetyl-CoA and
oxaloacetate. During the aldol condensation reaction between
acetyl-CoA and oxaloacetate, a thioester group (CoA) is
hydrolyzed, forming citrate (Gruetter, 2002). The flux through
succinate to fumarate oxidation reaction mediated by succinate
dehydrogenase enzyme (EC:1.3.5.1) was calculated in 0.06
µmol/g/min, which is consistent with previous studies that
estimate intracellular fluxes in primary cultures of astrocytes
(Amaral et al., 2011).
Furthermore, we detected activation fluxes in oxidative
phosphorylation reactions of the model. These reactions allowed
to oxidize the NADH resulting from TCA to generate ATP
(Mason et al., 1995). Additionally, it is possible that oxidative
phosphorylation produces a small proportion of reactive species
from oxygen (Murphy, 2009). Our model showed that oxidative
phosphorylation produced fluxes in the reactions that were
involved in the production of reactive species from oxygen,
such as hydrogen superoxide and peroxide. Thus, there is a
small flux activation in the ROS detoxifying reactions (Ivanov
et al., 2014). The flux balance analysis (FBA) suggested an
activation of pentose phosphate pathway with a production of
NADPH (Supplementary Data 4). This metabolite is used as
an electron donor in reductive reactions during biosynthesis
or in the detoxification of hydrogen peroxides and glutathione
maintenance (Bolaños et al., 2008).
Glutamate and Glutamine Cycle
One of the best characterized astrocytic function is the
rapid elimination of neurotransmitters released in the
synaptic cleft, an essential process for the termination of
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FIGURE 3 | Major metabolic fluxes (µmol/g tissue/min) in astrocyte under normal physiological conditions. The steady-state flux space distributions of the
reconstructed network were calculated through two objective functions that tested the metabolic pathways response: (1) ATP production maximization, and (2)
Glutamate absorption and glutamine secretion. The abbreviations used for metabolic pathways are: TCA, tricarboxylic acid cycle; PPP, pentose phosphate pathway;
Tyr, tyrosine; Gly, clycine; Ser, serine; Thr, threonine; Cys, cysteine; Met, methionine; Arg, Arginine; Pro, proline; Ala, alanine; Asp, asparagine; Glu, glutamate; Val,
valine; Leu, leucine; Ile, isoleucine.
transmission and maintenance of synaptic neuronal excitability
(Malarkey and Parpura, 2008). Glutamate is the main excitatory
neurotransmitter in the brain and it is especially critical due to its
neurotoxic properties. Under normal physiological conditions,
glutamate captured by cells can be used for metabolic purposes,
such as protein synthesis, energetic metabolism, ammonia
fixation, or as a neurotransmitter. In this sense, neurotransmitter
effects of glutamate in the synapsis are highly dependent on the
astrocyte (Hertz et al., 1999; Hertz and Zielke, 2004; Struzyn´ska,
2009). For this reasons, we evaluated the glutamate-glutamine
cycle in our model, through the use of the second objective
function and measurement of flux rates of glutamate uptake
through the system, changing glutamate uptake from 0.03 to
0.315µmol/g/min.
It was also observed that changes in glutamate uptake
had a greater impact on the calculated fluxes of aerobic and
anaerobic glycolysis. The fluxes in glucose production and
release of lactate increased as well, showing that our model is
in agreement with studies carried out on primary cultures of
cerebral cortical astrocytes, which measured these metabolites
by enzymatic and autoradiography techniques (Pellerin and
Magistretti, 1994). Likewise, glutamate uptake reduction was
correlated with a decrease in the metabolic flux exerted by
glutamine synthetase (EC 6.3.1.2), glutamate dehydrogenase
(EC 1.4.1.) and lactate dehydrogenase (1.1.1.27) (Figure 4).
Finally, the AKG production was proportionality increased
with glutamate uptake (from 0.0003 to 0.335 µmol/g/min).
These results are in agreement with previous glutamate labeling
experiments, in astrocytic primary cultures (Mason et al., 1992;
Schousboe et al., 1997; Chatziioannou et al., 2003). Figure 5
shows the main active pathways during simulation in normal
physiological conditions.
Potential of Reconstructed Model in the
Analysis of Pathological States
Brain ischemia results from stroke or head trauma, causing a
decrease in the brain energy supply that in some instances can
produce irreversible damage, being one of the main causes of
death worldwide (Hertz et al., 1999; Lebon et al., 2002). As
mentioned before, during ischemic strokes, astrocytes play an
important role in the protection of affected tissues given their
improved resistance to pathophysiological conditions and thus
helping in the protection of spared tissue from further damage,
by the production of growth factors, antioxidants and glutamate
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FIGURE 4 | Metabolic network states under effect of glutamate uptake under normal physiological conditions. Histograms of the steady-state flux space
are shown for glutamine, lactate, glucose, AKG (alfa-ketoglutarate), and ATP (adenosine triphosphate). During model simulation was observed that the glucose
uptake, lactate, glutamine and AKG production increased with increase in glutamate (the glutamate uptake from 0, 03 to 0, 310). (A) Flux of alpha ketoglutarate
increase dramatically, this is due to the activation of the deamination of the glutamate mediated by glutamate dehydrogenase. (B) activation of tricarboxilic cycle is
induced by the previous obtention of AKG, as consequence ATP synthesis increases. (C) consumption of glucose is increased to satisfy the glycolitic state in
astrocyte, however other sources of energy supply (D) related with the glutamine/glutamate cycle, glutamine are released to the extracellular space in order to satisfy
neuronal needs. (E) lactate released during glutamate uptake.
uptake (Swanson et al., 1997). Currently, the precise metabolic
determination of astrocytes during pathologies is chalenging
using experimental approaches. Thus, computational modeling
under restrictions can help to understand the global metabolic
changes and cellular functions that take place in different
pathologies. Given the importance of ischemia in astrocytes, an
ischemic episode was simulated and evaluated in our model.
To simulate ischemic conditions, a reduction in oxygen and
glucose flux was performed by progressive reductions of 20%
over the maximum rate of oxygen consumption defined in
normal physiological conditions (in a range of 0–0.530 µmol/g
of tissue/min) (Mason et al., 1995; Shen et al., 1999). Likewise,
glucose deprivation was generated by progressive reductions
of 20% over the maximum glucose intake defined in normal
physiological conditions (in a range of 0–0.490 µmol/g of
tissue/min). Flux distributions throughout the network were
calculated using Monte Carlo Sampling (Random Sampling)
(Wiback et al., 2004; Bordel et al., 2010). We took literature
data of different metabolic fluxes in astrocyte cultures exposed
to oxygen and glucose deprivation (Cruz and Cerdán, 1999;
Amaral et al., 2011). Such procedure allowed limiting flux space
of simulation, therefore flux values generated were more accurate
and allowed characterization of a feasible flux distribution for the
ischemic metabolic state in astrocytes.
Ischemic Conditions
Flux distributions on ischemic conditions were compared
with distributions calculated on the normal physiological state
(Supplementary Data 4). The results showed a significant flux
reduction of the reactions grouped in the metabolic pathways
of fatty acids oxidation, tricarboxylic acid cycle, oxidative
phosphorylation and glutamate-glutamine cycle. Likewise,
increases in fluxes through anaerobic glycolysis and pentose
phosphate pathways were observed (Figure 6). Previous studies
have shown that substrate limitations cause acceleration of
flux through these pathways (anaerobic glycolysis and pentose
phosphate pathway) and depression in the others (fatty acids
oxidation, tricarboxylic acid cycle, oxidative phosphorylation
and glutamate-glutamine cycle) (Swanson et al., 1997).
Mitochondria are the main organelles of ATP generation
at cellular level, and are mostly dependent on oxygen and
glucose reservoirs (Baker et al., 1998). Decreases in oxygen fluxes,
highly reduced the ATP production in the (Weisbrot-Lefkowitz
et al., 1998). Moreover, when evaluating different reactions
performed in the mitochondria, an important decrease in the
reaction fluxes within the TCA and oxidative phosphorylation
was observed. Importantly, the decrease in flux distributions in
these processes are general characteristics of astrocytes under
ischemic conditions (Sonnewald et al., 1994; Swanson et al., 1997;
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FIGURE 5 | Energetic state under normal physiological conditions in human astrocyte. Orange arrows show the active metabolic pathways in the normal
physiological astrocyte. The fluxes were calculated for maximizing the glutamate uptake /glutamine release/ ATP synthesis, using the uptake rates given in Table 1 as
constraints. Dashed arrows indicate the exchange reactions for metabolic transport across the network boundary. Only key pathway fluxes are represented here for
simplicity. All reactions are listed in Additional Files. The abbreviations used for metabolic pathways are: PPP, pentose phosphate pathway and Tyr, tyrosine; AKG,
α-ketoglutarate; GLT, glutamate.
Niitsu et al., 1999). Moreover, studies in primary cultures have
also shown that the dysfunction of Na+K+ATPase pump due
to ATP depletion is a fundamental event in brain ischemia (Yu
et al., 2002). Consequently, the inhibition of this pump during
ischemia causes a loss of cellular ionic gradients and membrane
depolarization (Chateil et al., 2001). In this aspect, our simulation
showed that Na+/K+ATPase flux decreased proportionally with
ATP reduction.
Regarding the behavior of anaerobic glycolysis reactions
in simulations, we observed that despite the increased flux
in this pathway, ATP production was notoriously diminished.
This may occur because cell energy balance is compromised
due to the reduction of glucose metabolism and decrease of
substrates needed for ATP production (oxygen and glucose).
In this aspect, respiration is inhibited but glycolysis continues
in astrocytes causing an accumulation in lactate and protons
and a rapid intracellular acidification (Kawamata et al., 1995).
When lactate behavior is assessed in the model, we found
an increased flux on lactate production reactions (Figure 7);
similar to previous experimental studies (Dienel and Hertz,
2005). This metabolic behavior can occur when glycolytic
anaerobic pathway in highly activated to compensate for the
partial inactivation of TCA cycle that happens in mitochondria
(Sonnewald et al., 1994).
On the other hand, the extracellular concentration of
glutamate is increased during brain ischemia. In this sense,
glutamate uptake by astrocytes is important in the regulation of
ischemic state. In ischemic conditions, the reduced energy status
in astrocytes can lead a disruption in the glutamate-glutamine
cycle (Dallas et al., 2007). In the simulation, we observed that
glucose and oxygen deprivation leads to the decrease in glutamate
uptake flux and glutamine release. As expected, glutamate uptake
flux falls into much lower levels during a severe ATP depletion,
indicating that glutamate internalization into the cell is mediated
directly by energetic requirements (Figure 7). The results of
the simulation are in accordance with studies carried out in
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FIGURE 6 | Qualitative properties for ischemic from literature compared with model results. Blue arrows show reactions with low flow or not activated and
the orange arrows indicate a high flow during simulation. The abbreviations used for metabolic pathways are: PPP, pentose phosphate pathway and Tyr, tyrosine;
AKG, α-ketoglutarate; GLT, glutamate.
astrocytes subjected to hypoxia (Swanson, 1992; Chateil et al.,
2001; Dallas et al., 2007).
Certain metabolic intermediaries, during ischemic
circumstances, can replace glucose and play a role as alternative
energy substrates (Chateil et al., 2001). One example is acetate,
which is an alternative substrate transported only to glial cells.
Acetate is its converted to acetyl-CoA by acetyl-CoA synthetase
(acetate–CoA ligase; EC 6.2.1.1), and then enters the TCA cycle
by condensing with oxaloacetate to form citrate. (Castelló-Ruiz
et al., 2014). Regarding the acetate uptake, our model showed
an increase in acetate absorption in response to oxygen and
glucose reduction, compared with normal conditions (Figure 7).
Moreover, in the model, we observed an increased flux in
antioxidant enzymes and key enzymes in glycolysis (Table 4).
In this aspect, many studies have shown that these enzymes can
be part of a machinery for cultured astrocytes to adapt to an
ischemic environment, suggesting that the overexpression of
antioxidant enzymes may be an important protective mechanism
that prevents brain injury (Sonnewald et al., 1994; Niitsu et al.,
1999; Grelli et al., 2013). Overall, the in silico predictions of our
model, are similar to those experimentally reported in ischemic
astrocytes, suggesting the predictive value of the present model.
DISCUSSION
A comprehensive model of astrocyte metabolism was generated
based on the analysis and integration of genomic, transcriptomic,
biochemical and physiological data, followed by manual
curation. Compared with previous metabolic models, this
reconstruction model is to our knowledge, the most complete
mathematical structured database (in term of metabolites/genes
and reactions), which would enable systematic studies of
human astrocyte metabolism. This model includes the central
routes of carbohydrate metabolism, energetic metabolism, purine
metabolism, aminoacids metabolism, vitamin and cofactor
metabolism, glutamate-glutamine cycle, lipid metabolism and
glutathione metabolism.
We studied the flux distribution in these pathways. For this
goal, two simulations were generated from this reconstruction,
representing the astrocyte in normal physiological state and
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FIGURE 7 | Astrocyte ischemia. Effect of glucose and oxygen deprivation of astrocytes on metabolic fluxes rates calculated with random sampling approach. The
global result, showed a significant increase in the tendency of the flux through anaerobic glycolysis and pentose phosphate pathway. Similarly, a reduction of the flux
of the reactions grouped in the metabolic routes of fatty acids oxidation, tricarboxylic acid cycle, oxidative phosphorylation, glutamate-glutamine cycle, and
Na+/K+ATPasa. (A) privation of sources of oxygen and glucose decrease gradually the synthesis of energy, until the model is unable to satisfy requirements. (B)
synthesis of lactate is useful as replacement of energy until there are no sources of energy that supply pumps to interchange other metabolites. (C) pumps and
transporters fluxes decrease with the energy depletion, among them glutamine (D) Acetate as an alternative source of energy is useful for model until transporters and
pumps did not work by the lack of energy. (E) Detoxification properties are decreased following the energetic depletion.
TABLE 4 | In silico predictions of changes in metabolic functions in ischemic conditions were compared with those reported in the literature.
Name enzyme E.C number Model prediction Experimental data References
Catalase EC:1.11.1.6 Up Up Gu et al., 2004; Armogida et al., 2011
Superoxide dismutase EC:1.15.1.1 Up Up Baker et al., 1998
Glutathione peroxidase EC:1.11.1.9 Up Up Weisbrot-Lefkowitz et al., 1998
Glyceraldehyde-3-phosphate dehydrogenase EC:1.2.1.12 Up Up Tanaka et al., 2002
Hexokinase EC:2.7.1.1 Up Up Niitsu et al., 1999
Nicotinamide phosphoribosyltransferase EC:2.4.2.12 Up Up Yamauchi et al., 2001; Wang et al., 2011;
Jing et al., 2014; Morris-Blanco et al., 2014
Phospholipase A2 EC:3.1.1.4 Up Up Muralikrishna Adibhatla and Hatcher, 2006
Isocitrate dehydrogenase EC:1.1.1.42 Down Down Grelli et al., 2013
Monoamine oxidase EC:1.4.3.4 Down Down Khvatova et al., 1997, 2007
Overall, in silico predictions of changes in metabolic function are similar to the changes reported experimentally in practices performed in astrocytes submitted to ischemia.
ischemic conditions. Through these simulations, we tried to gain
some insight into the metabolic pathways and metabolites that
were present in these metabolic states. In this aspect, the model
was capable of yielding results, which were in correspondence to
the experimentally proved phenomena.
By setting the objective function, the model was demanded to
generate the maximum energy production. Therefore, increased
fluxes in energetic pathways were observed. Specifically, a higher
activation in the TCA cycle pathway was observed, followed
by glycolysis, pentose phosphate and oxidative phosphorylation,
showing direct relations among these different cycles. Our
results shown glycolytic flux activation in response to an abrupt
energetic demand (e.g., glutamatergic neuronal excitation)
(Fu and Jhamandas, 2014; Ivanov et al., 2014). The model
can respond with the metabolic machinery to produce ATP,
showing oxidative activity and increasing energetic substrate
consumption. These results agree with recent studies reporting
that astrocytes express transcripts that predict self-sufficiency
in glycolysis as well as in oxidative metabolism (Lovatt
et al., 2007). Moreover, most enzymes participating in the
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tricarboxylic acids cycle (TCA) are expressed in high levels
in astrocytes (Panov et al., 2014), which was evident in the
model.
Flux distributions in simulations were related to the metabolic
tasks set in the model. For example, in a excitatory physiological
cellular state, the model responded by maximizing energy
production in response to the requirements generated by
the glutamate uptake. Experimental evidence suggest that
astrocytes present a high flux rate at glycolysis level, making
them “glycolytic cells” (Fu and Jhamandas, 2014; Ivanov
et al., 2014); however, they also have an important oxidative
metabolism especially toward glutamate (Bouzier-Sore and
Pellerin, 2013). Normal physiological glutamatergic state was
simulated in astrocyte by using restrictions and metabolic tasks
according to the studied system (simultaneous maximization
of the glutamate/glutamine cycle and ATP production). In this
simulation, we observed the relationship between glutamate
uptake and central metabolism, which is consistent with the
metabolic mechanisms reported in the literature. Experimental
evidence suggest that once a neuron has released glutamate to the
synaptic cleft, the astrocytes uptake the glutamate using several
transporters, e.g., excitatory amino acids transporters (EAAT);
for this transport, a symport between glutamate and sodium is
required, then a Na+, K+-ATPase supplies this ion inside the
astrocyte (Allaman et al., 2011). However, the latter requires a flux
of ATP that is supplied by the glycolytic and oxidative pathway of
the astrocyte (Schousboe et al., 2014).
The model also showed a high flux in glutamine synthetase
compared with other glutamate metabolizing enzymes,
suggesting that glutamate is predominantly converted into
glutamine due to an ATP-dependent reaction. Furthermore, the
increase in ATP production and glucose was related with the
increase in glutamate uptake (Figure 4). These observations are
consistent with the research of Pellerin and Magistretti, who
showed that glutamate stimulates glycolysis and ATP in cultures
of astrocytes (Magistretti and Pellerin, 1999). Glutamate, despite
being a neurotransmitter, also participates as a metabolite to
become in alpha ketoglutarate (Lying-Tunell et al., 2009; Ivanov
et al., 2014), it is incorporated in the TCA cycle to perform the
metabolic process of recycling pyruvate (Figures 4A,E) and ATP
production (Dienel, 2013).
Using radiolabeled glutamate, McKenna et al. (2009) and
Sonnewald determined through the production of 14CO2, that
extracellular glutamate could be metabolized to glutamine or
enter the TCA cycle as alpha ketoglutarate by transamination
mediated by the aspartate aminotransferase, as well as by direct
oxidation mediated by glutamate dehydrogenase (Grelli et al.,
2013; Castelló-Ruiz et al., 2014; Fu and Jhamandas, 2014).
Regarding the pyruvate cycle, it has also been determined by
radiolabeling that glutamate upon entering the TCA cycle can
be oxidized to malate or oxaloacetate by malic enzyme or the
combined action of phosphoenolpyruvate carboxykinase and
pyruvate kinase (McKenna, 2013). On the other hand, the
production of lactate and glutamine was increased as a normal
mechanism of astrocyte (Figures 4D,E), for example to supply
the neuron with metabolites and neurotransmitters (Allaman
et al., 2011).
The primary insult to which brain cells are exposed during
ischemia is the decrease on substrates such as glucose and oxygen.
A critical event, considering that brain cells require a continuous
supply of oxygen and energetic substrates for maintenance of
its functional and structural integrity (Castelló-Ruiz et al., 2014;
Kuroiwa et al., 2016). Astrocytes have multiple functions in
several metabolic aspects of ischemic brain damage, because they
are capable of protecting neurons against numerous insults, and
in that way promoting neuronal survival. In this aspect, astrocyte
dysfunction may lead to an alteration of the normal homeostasis
between neuron and astrocyte, causing metabolic changes with
consequent cell death.
Ischemia is an example in which astrocytes seem to play a
“paradoxical role” in neuronal survival (Molofsky et al., 2012).
Severe ischemia leads to an undersupply of oxygen, glucose
and energy, for astrocytes. Brain damage during and after
ischemic events is associated with reduced energy production
(ATP), decreased glutamate clearance, and increased acidosis
due to an increase in lactate production (Rossi et al., 2007).
In consequence, mechanisms of ATP depletion, intracellular
acidification and generation of reactive oxygen species are
involved in the pathophysiology and severity of cell damage in
ischemia (Rossi et al., 2007). Several experimental studies have
shown that glycolitic enzymes are regulated under ischemia, in
order to stabilize ATP levels and protect neuronal survival (Cruz
and Cerdán, 1999; Dienel and Hertz, 2005; Rossi et al., 2007).
Although the model did not allow any prediction over time
course, because kinetic values were not taking into account, our
results emphasized the possible metabolic change in the different
foci of ischemia (Swanson et al., 1997).
Our model also showed a progression in the activation of
astrocytic protective effects during ischemic state (Figure 6).
While the amount of ATP production decreased, the activity
of some reactions that required this substrate were limited.
Then, the astrocytic metabolism changed toward metabolic
alternatives that allowed cell survival or the feasible solution
in the stoichiometric matrix. One of these alternatives was an
increase in lactate production (Figure 7C), which allowed NAD+
recovery and ATP production from glycolysis. Subsequently,
enzymes of the glycolytic pathway became activated, specifically,
hexokinase (EC 2.7.1.1) and glyceraldehyde 3-phosphate
dehydrogenase (EC:1.2.1.12). The latter not only catalyzes
the sixth step of glycolysis, but also has been involved in
non-metabolic processes including transcription, apoptosis and
axonal transport (Tanaka et al., 2002; Suzuki et al., 2015). Thus,
production of lactate increased to satisfy the energy requirements
by NAD+, because astrocytes can produce lactate for neuronal
oxidative phosphorylation in response to ischemic state in order
to maintain continuous neurotransmission (Lying-Tunell et al.,
2009). To meet this requirement, astrocytes support neurons
by balancing different glycolytic fluxes (Ivanov et al., 2014).
Consequently, compensatory glycolysis does not prevent the
decrease in ATP level during the last stages of ischemic state
simulation.
One of the best-characterized functions of astrocytes is
the quick removal of neurotransmitters released into the
synaptic cleft, an essential process for the termination of
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synaptic transmission and maintenance of neuronal excitability
(Guillamón-Vivancos et al., 2015). The decrease of ATP in the
model has severe consequences in this metabolic process, because
the Na, K-ATPase requires a constant source of ATP, and for
this reason the release or uptake of different metabolites can be
altered. Additionally, glutamate transport requires sodium which
is provided by these pumps (Hertz et al., 1999; Danbolt, 2001).
During ischemia, Sodium pump failures are associated with the
raise of extracellular concentration of glutamate, which triggers
excitotoxicity. These results are consistent with the hypothesis
that ischemia leads to lower glutamate transport in astrocytes
(Sonnewald et al., 1994; Anderson and Swanson, 2000). Model
simulated ischemia (i.e., zero uptake of oxygen and glucose),
highly reduced the glutamate uptake and glutamine release.
During the initial steps of ischemia both, Na+,K+-ATPase
and glutamate transporters are overexpressed as a survival
mechanism, which correlates with a rise in glutamate uptake
(Figure 7E) (Kim et al., 2013).
During severe ischemia, there is an increased astrocytic dead,
as seen in Figure 7, where in the total deprivation of glucose and
oxygen the decay of any other process is absolute (Figures 7A–E).
Additionally, we have also identified changes in some antioxidant
enzymes, such as catalase, superoxide dismutase and Glutathione
peroxidase. Recent studies have shown that astrocytes maintain
high antioxidative concentrations, making themmore resilient to
oxidative stress than neurons. For that reason, under ischemic
conditions astrocytes increases the expression of antioxidant
enzymes (Raps et al., 1989; Semsei et al., 1991; Espinosa-
Diez et al., 2015; Finsterwald et al., 2015). Additionally,
other enzymes related with mitochondrial dysfunction such as
Isocitrate dehydrogenase (EC:1.1.1.42) and monoaminoxidase
(EC:1.4.3.4), had been related with a decrease in their activity,
first is associated to the lack of NAPD+ inside the cell, and the
latter with lower levels of oxygen inside the cell which inhibits
oxidative deamination (Khvatova et al., 1997, 2007).
In conclusion, we generated the most complete metabolic
reconstruction of an astrocytic to the date. In this aspect,
the simulation of different conditions in or astrocytic model
were positively correlated with previous studies (Danbolt, 2001;
Allaman et al., 2011; Jackson et al., 2014); showing that the
in silico astrocyte model presented here, is able to represent
metabolic behaviors and simulates changes in metabolic fluxes
in response to normal physiological state and ischemia. This
reconstruction is fully compatible with the Human metabolic
atlas, enabling the of astrocyte-cells interactions. In this sense,
this metabolic model will also allow the scientific community
to dynamize the identification of metabolic routes associated to
different phenotypes (aging diseases, injuries, etc.), identification
of active therapeutic targets, discovering of key proteins in
response to an insult (metabolic, deprivation, etc.), future
drug evaluations and determination of biomarkers in different
neurologic diseases such as Alzheimer, Parkinson, Huntington,
Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Schizophrenia,
among others. The study of the metabolic behavior of these
diseases during aging will help to understand characteristics
of receptors, transporters and pumps that are vital in the
development of these processes (De Lores Arnaiz and Ordieres,
2014). Finally, we demonstrated the high-quality astrocyte model
is very well suited for integration of omics data and hereby result
in a compressive understanding of astrocyte biology in response
different metabolic phenotypes.
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